The symposium is currently open to free abstract submission.
We welcome abstracts focused on liver disease and tumors, including pathology, diagnostics, tumors, and treatment modalities.
“Liver tumors” include, but are not limited to: hepatocellular carcinoma, bile duct cancers, gall bladder cancer, liver metastases, hepatoblastoma, and benign liver tumors (ie, adenoma, FNH, etc).
Encore presentations are welcome!
The top 3 abstracts will be selected for oral presentation.
Registration for SALCS 2025 has opened with fees starting at $150. (Note: Patient Advocates can attend free after verification of attestation.) The first 75 people to register can save $50 as early birds.
SALCS offers many opportunities for industry to meet doctors and other leaders in the liver cancer field. The exhibition is now open for applications.
The Westin in North San Antonio will host the 2025 San Antonio Liver Cancer Symposium on October 9 and 10, 2025.
Book your room through us to get a discounted rate.
Sukeshi Patel Arora, MD, is an associate professor in the Division of Hematology and Medical Oncology at The University of Texas Health San Antonio and is the leader of the gastrointestinal malignancies and geriatric oncology program at Mays Cancer Center.
Danielle Fritze, MD, is an associate professor in the Division of Organ Transplantation at The University of Texas Health San Antonio. She specializes in liver and kidney transplantation and surgery of the liver, bile duct, and pancreas.
7979 Wurzbach Road | San Antonio, TX 78229 US
Telephone: +1 210-450-1550
Email: UTHealthMTG@uthscsa.edu